# Otsuka Pharmaceutical Development & Commercialization, Inc. – FDA Inspection, Mar 18, 2014

Source: https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/4ae736dc-c8ef-478e-819a-5439f8e8e120
Source feed: FDA_Inspections

> FDA inspection 868761 of Otsuka Pharmaceutical Development & Commercialization, Inc., March 18, 2014. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 868761
- Company Name: Otsuka Pharmaceutical Development & Commercialization, Inc.
- Inspection Date: 2014-03-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1276733 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/f511ad3b-3616-4cda-bc99-e643315dc9a0)
- FDA Inspection 1001627 - 2017-02-03

Company: https://www.keypedia.com/companies/otsuka-pharmaceutical-development-commercialization-inc/a1427d0e-e216-46ba-9158-bc52701a7a70

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c